Stories about research and scientific development at Mount Sinai
Mount Sinai Streamlines its Research Administration Enterprise
The Icahn School of Medicine at Mount Sinai has begun rolling out a series of projects for investigators in basic, translational, and clinical research that will streamline the research administration structure and make it easier to initiate and submit protocols and...
New Discoveries in Head and Neck Cancers
Shutting down inflammation within the body, and then harnessing the immune system to recognize and destroy cancer cells, could provide the one-two punch needed to effectively treat head and neck cancers, according to researchers at Icahn School of Medicine at Mount...
First Generation Scholars
In 2008, a first-year medical student named Jennifer Ling developed a program called the First Generation College Application Essay Writing and Scholarship Program, under the sponsorship of Students for Equal Opportunity in Medicine (SEOM). There were six students in...
Baby Boomers Should Get Tested for Hepatitis C!
According to the CDC, all “Baby Boomers” should get tested for hepatitis C. This is based only on age and for this recommendation Baby Boomers are defined as those born between 1945 and 1965 Hepatitis C (HCV) is a viral infection of the liver that can lead to...
Leadership in Scientific Education
The Graduate School of Biomedical Sciences has been training many of our nation’s finest scientists for more than four decades and inspiring them to translate their discoveries into effective treatments for human diseases. Today, Mount Sinai is a leader in bringing...
Cancer Researcher Ramon E. Parsons, MD, PhD, Joins Mount Sinai
Ramon E. Parsons, MD, PhD, a highly acclaimed researcher in cancer genetics, has joined Icahn School of Medicine at Mount Sinai as the Ward-Coleman Chair in Cancer, and Chair of the Department of Oncological Sciences. Dr. Parsons succeeds Stuart Aaronson, MD, Jack and...
New Myelofibrosis Drug Holds Promise
In a phase I clinical trial, physicians at The Mount Sinai Medical Center have identified the first drug that appears to stop the progression of myelofibrosis, a life-threatening blood cancer. The investigators found that, at low-doses, panobinostat (LBH589)...
Roger J. Hajjar, MD, To Be Honored for Research
Roger J. Hajjar, MD, a pioneering Mount Sinai researcher who has published cutting-edge studies on heart failure, has been named the recipient of the 2013 BCVS Distinguished Achievement Award by the American Heart Association and the Council on Basic Cardiovascular...
Breaking Through Autism
The Center for Disease Control and Prevention has found that 1 in 88 people are affected by autism spectrum disorders (ASD), a disorder four times more common in boys than in girls. At the Seaver Autism Center for Research and Treatment, we are dedicated to...